Makers Laboratories
159.95
+0.95(+0.60%)
Market Cap₹94.36 Cr
PE Ratio15.95
IndustryHealthcare
Company Performance:
1D+0.60%
1M-0.12%
6M+29.88%
1Y+18.22%
5Y-27.52%
View Company Insightsright
More news about Makers Laboratories
11Aug 25
Makers Laboratories Reports 18.3% Revenue Growth and Return to Profitability in Q1
Makers Laboratories Ltd announced Q1 results, showing significant improvement. Total income from operations increased 18.3% to Rs. 3,500.10 lakhs. The company returned to profitability with a net profit after tax of Rs. 128.61 lakhs, compared to a loss of Rs. 70.39 lakhs in the previous year. Net profit before tax rose 371% to Rs. 197.63 lakhs. Earnings per share improved to Rs. 0.74 from a loss of Rs. 1.67. The company's standalone performance also showed improvement, reducing losses. Equity share capital remained stable at Rs. 590.04 lakhs.
 no imag found
08Aug 25
Makers Laboratories Reports Mixed Q1 Results: Standalone Loss, Consolidated Profit
Makers Laboratories Ltd reported mixed Q1 financial results. Standalone operations showed a net loss of Rs 121.89 crore and 21% lower revenue at Rs 970.07 crore. However, consolidated results improved with a net profit of Rs 43.67 crore, despite a 15.5% decrease in revenue to Rs 2,959.17 crore. The Chemical Manufacturing segment outperformed the Pharmaceutical segment, contributing significantly to the consolidated profit. CEO Samhita Parikh emphasized the company's commitment to improving operational efficiency and capitalizing on growth opportunities.
 no imag found
Makers Laboratories
159.95
+0.95
(+0.60%)
1 Year Returns:+18.22%
Industry Peers
Sun Pharmaceutical
1,824.80
(-1.13%)
Divis Laboratories
6,796.00
(+2.29%)
Torrent Pharmaceuticals
4,295.80
(-1.96%)
Cipla
1,327.60
(+2.73%)
Dr Reddys Laboratories
1,265.30
(-0.37%)
Lupin
2,215.60
(-1.33%)
Mankind Pharma
2,407.60
(+1.21%)
Zydus Life Science
939.25
(+0.92%)
Aurobindo Pharma
1,497.50
(+0.62%)
Laurus Labs
1,280.50
(+0.99%)